Protease inhibitors: Current status and future prospects

被引：837

作者：

Leung, D ^{[1
]}

Abbenante, G ^{[1
]}

Fairlie, DP ^{[1
]}

机构：

[1] Univ Queensland, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2000年 / 43卷 / 03期

关键词：

D O I：

10.1021/jm990412m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：305 / 341

页数：37

共 359 条

[1]

Abad-Zapatero C, 1998, ADV EXP MED BIOL, V436, P297

[2]

AbadZapatero C, 1996, PROTEIN SCI, V5, P640

[3]

Abe O, 1994, Gan To Kagaku Ryoho, V21, P845

[4]

ADANG AEP, 1994, RECL TRAV CHIM PAY B, V113, P63

[5] Amprenavir [J].

Adkins, JC ;

Faulds, D .

DRUGS, 1998, 55 (06) :837-842

[6]

ALLEN M, 1998, 215 ACS NAT M DALL T

[7] Human ICE/CED-3 protease nomenclature [J].

Alnemri, ES ;

Livingston, DJ ;

Nicholson, DW ;

Salvesen, G ;

Thornberry, NA ;

Wong, WW ;

Yuan, JY .

CELL, 1996, 87 (02) :171-171

[8]

ANDERSON GP, 1999, CURR OPIN ANTIINFLAM, V1, P29

[9] INHIBITION OF HUMAN NEUTROPHIL ELASTASE WITH PEPTIDYL ELECTROPHILIC KETONES .2. ORALLY-ACTIVE P-G-VAL-PRO-VAL PENTAFLUOROETHYL KETONES [J].

ANGELASTRO, MR ;

BAUGH, LE ;

BEY, P ;

BURKHART, JP ;

CHEN, TM ;

DURHAM, SL ;

HARE, CM ;

HUBER, EW ;

JANUSZ, MJ ;

KOEHL, JR ;

MARQUART, AL ;

MEHDI, S ;

PEET, NP .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (26) :4538-4553

[10] INACTIVATION OF CALPAIN BY PEPTIDYL FLUOROMETHYL KETONES [J].

ANGLIKER, H ;

ANAGLI, J ;

SHAW, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (02) :216-220

← 1 2 3 4 5 6 7 8 9 10 →